CYP19A1 and endometrial cancer: Hormonal treatments for endometrial cancer include tamoxifen, GnRHa, aromatase inhibitors (AIs), progestins, and luteinizing hormone-releasing hormone agonists (LHRH agonists) (Figure 2) [105].